# Achieve Life Sciences, Inc.: Form 8-K, filed Apr 16, 2026

- Company: [Achieve Life Sciences, Inc.](/companies/achv.md) (CIK 949858)
- Form: 8-K
- Filed: 2026-04-16
- Accepted by EDGAR: Apr 16, 2026, 16:47 ET
- Period: 2026-04-15
- Accession: 0001193125-26-159189
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/949858/000119312526159189/achv-20260415.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/949858/000119312526159189/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/949858/000119312526159189/achv-20260415.htm

Filed Apr 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-159189. Last ingested by Listed: Nov 11, 2026, 00:38 ET. No prices; not investment advice.
